Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Commerzbank CEO Says UniCredit Approval Could Come by Early Next Yearmarketbeat.com
Commerzbank (ETR:CBK) CEO Bettina Orlopp said the lender is entering a new phase as regulatory approvals related to UniCredit’s investment are expected by the end of the year or early next year, while emphasizing that the bank remains independently managed and focused on meeting its existing financi
Via MarketBeat · September 27, 2026
Gold, Silver, and Copper Prices Are Gaining Steam: 2 Mining Stocks Back in Favourfool.ca
Mining stocks are back in favour driven by higher average realized prices as gold, silver, and copper gained steam and hit record high.
Via The Motley Fool · September 27, 2026
2 Nuclear Stocks Crashed by About 50% in 2026. Here's the 1 Thing That Would Bring Them Back.fool.com
Many stocks in the nuclear space have lost ground this year.
Via The Motley Fool · September 27, 2026
Warren Buffett Steps Down as Chairman of Berkshire Hathaway: Here Are 3 of His Biggest Investing Lessons You Need to Knowfool.com
The average investor out there can learn so much from the Oracle of Omaha, even though his role has changed.
Via The Motley Fool · September 27, 2026
CAVA Stock Slips: Sector Fear or Valuation Reality?marketbeat.com
CAVA stock fell alongside restaurant peers after weak August traffic data, but Q2 results showed strong sales and unit growth despite slipping margins and a still-rich valuation.
Via MarketBeat · September 27, 2026
3 Top Canadian Stocks to Buy With $500 This Septemberfool.ca
Three top Canadian stocks just posted strong results, yet their shares have pulled back. Here's why $500 could work hard in each of them this September.
Via The Motley Fool · September 27, 2026
Tesla Reports Q3 Deliveries in Early October. Here's the Number That Would Send the Stock Soaring.fool.com
The company's deliveries report is eagerly awaited, as it offers a sneak peek at its third-quarter earnings.
Via The Motley Fool · September 27, 2026
Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?fool.com
The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027.
Via The Motley Fool · September 27, 2026
I’m Locking These 3 Dividend Stocks Into My TFSA for the Long Runfool.ca
Here are three top dividend stocks that could be excellent additions to your TFSA.
Via The Motley Fool · September 27, 2026
Social Security's Trump Bump-Fueled 2027 COLA Is Set to Make History 2 Different Waysfool.com
A projected well-above-average Social Security raise in 2027 should lead to some unique situations for beneficiaries.
Via The Motley Fool · September 27, 2026
How to Make Sure Your Roth Conversion Doesn't Backfirefool.com
Before jumping in, do the math.
Via The Motley Fool · September 27, 2026
The “Set it and Forget it” Dividend Stock That Just Keeps Payingfool.ca
Brookfield Infrastructure Partners is a top "set and forget" dividend stock for growing income. Here's why.
Via The Motley Fool · September 27, 2026
Does the S&P 500 Have a "Magnificent Seven" Problem? Here's What Investors Need to Know.fool.com
If the artificial intelligence revolution doesn't live up to the hype, the whole market is going to feel it.
Via The Motley Fool · September 27, 2026
Houston, Amazon.com Has a Problem -- and It's in Europe!fool.com
Arianespace was Amazon's last chance to keep its Leo satellite constellation growing this year. No longer.
Via The Motley Fool · September 27, 2026
Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flowmarketbeat.com
Prestige Consumer Healthcare (NYSE:PBH) said its strategy centers on investing in established over-the-counter brands, maintaining a high-margin operating model and using free cash flow for debt reduction, acquisitions and other shareholder-value initiatives. Speaking at a fireside chat, Chief Fina
Via MarketBeat · September 27, 2026
Canada Wants to Become an Energy Superpower: 3 TSX Stocks I’d Buy Nowfool.ca
Canada’s “energy superpower” pitch isn’t just about resources; it’s about the pipes, fuel, and wires that turn them into exports.
Via The Motley Fool · September 27, 2026
Why Equal-Weight Funds Hide A Yield Curve Catchmarketbeat.com
SPY's tech-heavy structure and RSP's equal-weight, rate-sensitive value tilt carry different risks; comparing yields, valuations, and margins helps investors position portfolios for shifting Treasury rates.
Via MarketBeat · September 27, 2026
If I Had $10,000 for 1 Dividend Grower, This Would Be Itfool.com
Investors have an increasingly attractive income and growth opportunity in PepsiCo stock.
Via The Motley Fool · September 27, 2026
Can McDonald's Stock Reclaim Its All-Time High as Rising Prices Weigh on Consumers?fool.com
The company's shares may have peaked at $341 per share.
Via The Motley Fool · September 27, 2026
60% of Americans Own Stock: That's Still Too Low. Here's the Contrarian Case for Why It Matters.fool.com
A little over half of Americans own stock, which means that too many people are missing out on the wealth-building power of capitalism.
Via The Motley Fool · September 27, 2026
Statistics Say This Is the Best Age to Claim Social Securityfool.com
There's one sure-fire way to know when to claim, but you will still have to settle for a best guess.
Via The Motley Fool · September 27, 2026
5 Scary-Good Stocks With Strong October Catalysts and Breakout Potentialmarketbeat.com
AMD, Credo Technologies, Bloom Energy, Target and LightPath Technologies show bullish chart setups and fundamental tailwinds ahead of Q3 earnings that could fuel gains by year's end.
Via MarketBeat · September 27, 2026
In 5 Years, One of These Cryptocurrencies Could Be Worth More Than Bitcoinfool.com
Several fast-growing cryptocurrencies have the potential to overtake Bitcoin. But can they maintain their momentum over the long haul?
Via The Motley Fool · September 27, 2026
History Says This Could Be the Smartest Growth ETF to Buy With $1,000 Right Nowfool.com
The growth stocks of smaller companies could be the next big opportunity.
Via The Motley Fool · September 27, 2026
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growthmarketbeat.com
Kamada (NASDAQ:KMDA) outlined its growth strategy, product portfolio and financial outlook during a company presentation, emphasizing demand for specialty plasma-derived therapies and a plan to expand through product sales, distribution agreements, plasma supply and potential acquisitions. The comp
Via MarketBeat · September 27, 2026